# 89bio, Inc.

89bio, Inc. is a company headquartered in San Francisco, CA, United States.

## Company overview

- **Legal name:** 89bio, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001785173

## About

89bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001785173, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported net income of USD -367,079,000; total assets of USD 478,685,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$367.1M (USD -367,079,000)
- **Total assets:** $478.7M (USD 478,685,000)
- **Cash and equivalents:** $126.1M (USD 126,060,000)
- **Operating cash flow:** -$367.8M (USD -367,823,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$142.2M (USD -142,189,000)
- **Total assets:** $596.3M (USD 596,269,000)
- **Cash and equivalents:** $316.2M (USD 316,161,000)
- **Operating cash flow:** -$129.2M (USD -129,186,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$102.0M (USD -102,026,000)
- **Total assets:** $196.8M (USD 196,824,000)
- **Cash and equivalents:** $55.3M (USD 55,255,000)
- **Operating cash flow:** -$81.1M (USD -81,090,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$90.1M (USD -90,122,000)
- **Total assets:** $162.4M (USD 162,422,000)
- **Cash and equivalents:** $52.4M (USD 52,432,000)
- **Operating cash flow:** -$76.8M (USD -76,781,000)

## Recent SEC filings

- Form 8-K — filed 2025-10-30 — period 2025-10-30 — 8-K
- Form 8-K — filed 2025-09-18 — period 2025-09-17 — 8-K
- Form 10-Q — filed 2025-08-08 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-07 — period 2025-08-07 — 8-K
- Form 8-K — filed 2025-05-30 — period 2025-05-28 — 8-K
- Form 10-Q — filed 2025-05-02 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-01 — period 2025-05-01 — 8-K
- Form DEF 14A — filed 2025-04-15 — period 2025-05-28 — DEF 14A
- Form 8-K — filed 2025-04-09 — period 2025-04-09 — 8-K
- Form 10-K — filed 2025-02-27 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-02-27 — period 2025-02-27 — 8-K
- Form 8-K — filed 2025-02-04 — period 2025-01-31 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/89bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology